News
Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...
1d
MedPage Today on MSNAdjuvant Cemiplimab Improves Disease-Free Survival in High-Risk Cutaneous SCCAdjuvant cemiplimab (Libtayo) significantly improved disease-free survival (DFS) compared with placebo in patients at high ...
CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...
In the Phase 1/1b trial, ficerafusp alfa in combination with pembrolizumab resulted in deep and durable anti-tumor activity with improved overall survival (OS) compared to historical benchmarks in ...
Adjuvant Opdivo, cisplatin and radiotherapy improved DFS vs other treatment among those with locally advanced squamous cell ...
Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.
Key Words: epidemiology, oral squamous cell carcinoma, human papillomavirus. Oral cancer includes cancer of the lip and oral cavity ( buccal mucosa, gingiva, hard palate, tongue and floor of mouth) (1 ...
AgNORs were studied in 24 biopsies from oral cavity (5 cases of normal oral mucosa, 5 of pseudocarcinomatous hyperplasia and 14 of squamous cell carcinoma, subdivided according to degree of ...
aState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China bGuangdong Esophageal Cancer ...
What is squamous cell carcinoma? Also called squamous cell skin cancer, this is a common type of skin cancer. It tends to develop in people who have had lots of sun exposure, use(d) tanning beds, or ...
To address this, researchers developed a "cell line atlas," which is a collection of cancer cell lines—each derived from an individual patient's tumor and adapted to grow in the lab—with ...
ADRX-0706 has received FDA fast track designation for the treatment of metastatic or locally advanced squamous cell cervical cancer. The nectin-4–targeted antibody-drug conjugate (ADC) ADRX-0706 has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results